CAR T-Cell Symposium 2019
UChicago CAR T-Cell Symposium 2019
Mechanisms of Acquired CAR-T Cell Resistance: Is There a 'Best' in Product, Target Antigen, and Tumor Type?
FEATURING
James Labelle
- 205 views
- October 24, 2019
- 1
UChicago CAR T-Cell Symposium 2019
Current Grading and Management Strategies of CAR-T Toxicities: Cytokine Release Syndrome (CRS)
FEATURING
Satyajit Kosuri
- 272 views
- October 24, 2019
- 2
UChicago CAR T-Cell Symposium 2019
Patient Selection for CAR T-Cell Therapy: Therapeutic Benefits, Discussion of Toxicities and Physiologic Reserve
FEATURING
Michael Leukam
- 548 views
- October 24, 2019
- 4
UChicago CAR T-Cell Symposium 2019
2019 Update on CAR-T in Multiple Myeloma - Can We Improve Upon These Results?
FEATURING
Jagoda Jasielec
- 244 views
- October 24, 2019
- 1
UChicago CAR T-Cell Symposium 2019
Why Does CAR T-Cell Therapy Fail? An Update on Mechanisms of Resistance/Relapse
FEATURING
Justin Kline
- 1,107 views
- October 24, 2019
- 5